Ryan Specialty EVP/CHRO Michael Conklin Receives Stock Award

What Happened

• Michael Conklin, EVP & CHRO of Ryan Specialty Holdings, was granted a derivative award on 2026-08-04 covering 22,920 shares. The filing reports an acquisition price of $0.00 (derivative securities), so no cash was paid at grant and no immediate shares were received.
• The award is an option-like grant exercisable 1-for-1 for Class A common stock; it does not represent immediately tradeable shares until vesting and exercise.

Key Details

• Transaction date: 2026-08-04; Form 4 filed: 2026-08-06 (appears timely within typical 2-business-day reporting window).
• Amount: 22,920 derivative shares; reported acquisition price: $0.00.
• Shares owned after transaction: not specified in the filing.
• Footnote: Options vest in equal amounts on October 1, 2029, 2030 and 2031 and are exercisable 1-for-1 for Class A common stock. Grant was approved by the compensation and governance committee for purposes of Rule 16(b)(3).

Context

• This is a compensation award (long-term incentive), not a market purchase or sale; it’s intended to reward and retain management and only converts into actual shares if/when vested and exercised.
• Because the grant was reported as a derivative award, there’s no immediate cash proceeds or share sale to interpret as bullish or bearish market activity.